These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23621126)

  • 1. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
    Du Y; Liu M; Gao J; Li Z
    Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
    Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
    Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
    Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
    Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer.
    Liu J; Gao J; Du Y; Li Z; Ren Y; Gu J; Wang X; Gong Y; Wang W; Kong X
    Int J Cancer; 2012 Aug; 131(3):683-91. PubMed ID: 21913185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).
    Subramani R; Gangwani L; Nandy SB; Arumugam A; Chattopadhyay M; Lakshmanaswamy R
    Int J Oncol; 2015 Oct; 47(4):1203-10. PubMed ID: 26314882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature.
    Wnuk J; Strzelczyk JK; Gisterek I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
    Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer.
    Link A; Becker V; Goel A; Wex T; Malfertheiner P
    PLoS One; 2012; 7(8):e42933. PubMed ID: 22905187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.
    Chen D; Wu X; Xia M; Wu F; Ding J; Jiao Y; Zhan Q; An F
    Oncol Rep; 2017 Oct; 38(4):2182-2188. PubMed ID: 28849236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
    Deng B; Wang M; Liu Z
    Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
    Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
    BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in miRNA gene signaling pathways in pancreatic cancer.
    Vorvis C; Koutsioumpa M; Iliopoulos D
    Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
    Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
    Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.
    Deng S; Zhu S; Wang B; Li X; Liu Y; Qin Q; Gong Q; Niu Y; Xiang C; Chen J; Yan J; Deng S; Yin T; Yang M; Wu H; Wang C; Zhao G
    Cancer Lett; 2014 Dec; 355(2):184-91. PubMed ID: 25172416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
    Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
    Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
    Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
    Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
    Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of key microRNAs in pancreatic cancer development.
    Baradaran B; Shahbazi R; Khordadmehr M
    Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.